Genomic biomarkers analyze DNA by identifying irregular sequences in the genome, typically a single nucleotide polymorphism.  Genetic biomarkers are particularly significant in cancer because most cancer cell lines carry somatic mutations.  Somatic mutations are distinguishable from hereditary mutations because the mutation is not in every cell; just the tumor cells, making them easy targets.